Handok "Rezolute’s Hyperinsulinism Treatment Receives FDA Breakthrough Therapy Status" Handok's affiliate, Rezolute, announced on the 7th (local time) that the U.S. Food and Drug Administration (FDA) has… Cheon Okhyeon 2025-01-08